2. Search Result
Search Result
Results for "

Spiramycin

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

5

Natural
Products

2

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-100593
    Spiramycin
    1 Publications Verification

    Rovamycin

    		 Bacterial Parasite Antibiotic Infection
    Spiramycin (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect. Spiramycin is composed of a 16-member lactone ring, on which three sugars (mycaminose, forosamine, and mycarose) are attached .
    Spiramycin
  • HY-N7141
    Spiramycin I

    		Parasite Antibiotic Bacterial Infection
    Spiramycin I is a macrolide antibiotic and antiparasitic .
    Spiramycin I
  • HY-B1916
    Acetylspiramycin
    2 Publications Verification

    Spiramycin B; Spiramycin II; Foromacidin B

    		 Antibiotic Bacterial Parasite Infection
    Acetylspiramycin (Spiramycin B) is an effective oral macrolide antibiotic produced by Streptomyces, It can inhibit the splenic lymphocyte transformation induced by phytohemagglutinin (PHA), LPS (HY-D1056) and antigen, reduce the procoagulant activity of macrophages, have good antibacterial effect on gram-positive bacteria, and is also an effective antigenic insect agent, which can be used to fight parasitic infection .
    Acetylspiramycin
  • HY-N7141R
    Spiramycin I (Standard)

    		Parasite Antibiotic Bacterial Infection
    Spiramycin I (Standard) is the analytical standard of Spiramycin I. This product is intended for research and analytical applications. Spiramycin I is a macrolide antibiotic and antiparasitic .
    Spiramycin I (Standard)
  • HY-120809
    Spiramycin III

    		Bacterial Parasite Antibiotic Infection
    Spiramycin III (SPMIII) is a main component of Spiramycin. Spiramycin (HY-100593) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect .
    Spiramycin III
  • HY-100593R
    Spiramycin (Standard)

    		Bacterial Parasite Antibiotic Infection
    Spiramycin (Standard) is the analytical standard of Spiramycin. This product is intended for research and analytical applications. Spiramycin (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect. Spiramycin is composed of a 16-member lactone ring, on which three sugars (mycaminose, forosamine, and mycarose) are attached .
    Spiramycin (Standard)
  • HY-W890109S
    Spiramycin I-d3-1

    		Isotope-Labeled Compounds Others
    Spiramycin I-d3-1 is deuterium-labeled Spiramycin I .
    Spiramycin I-d3-1
  • HY-100593A
    Spiramycin (hexanedioate)

    Rovamycin (hexanedioate)

    		 Parasite Antibiotic Bacterial Infection
    Spiramycin hexanedioate (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect. Spiramycin hexanedioate is composed of a 16-member lactone ring, on which three sugars (mycaminose, forosamine, and mycarose) are attached .
    Spiramycin (hexanedioate)
  • HY-143623S
    Neo Spiramycin I-d3

    		Isotope-Labeled Compounds Others
    Neo Spiramycin I-d3 is the deuterium labeled Neo Spiramycin I (HY-143623) . Neo Spiramycin I (NSPI) is the active metabolite of Spiramycin (SPI) with antimicrobial activity. Neo Spiramycin is widely used in veterinary medicine .
    Neo Spiramycin I-d3
  • HY-W587414
    Neospiramycin I

    		Bacterial Antibiotic Infection
    Neospiramycin I is a macrolide antibiotic and a derivative of Spiramycin I (HY-N7141). Neospiramycin I is effective against the macrolide-sensitive KB210 strain of S. aureus, but ineffective against the macrolide-resistant KB224 strain, with minimum inhibitory concentrations (MIC) of 3.12 and greater than 100 µg/mL, respectively; it is also effective against B. cereus, B. subtilis, M. luteus, E. coli, and K. pneumoniae, with respective MIC values of 1.56, 3.12, 3.12, 0.2, 50, and 12.5 µg/mL. Neospiramycin I binds to the ribosomes of E. coli, with an inhibitory concentration 50 (IC50) of 1.2 µM. It protects mice from death in a type III S. pneumoniae infection model, with an effective dose 50 (ED50) of 399.8 mg/kg .
    Neospiramycin I

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: